Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Operating Margin (2016 - 2025)

Historic Operating Margin for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to 1.43%.

  • Ptc Therapeutics' Operating Margin rose 291300.0% to 1.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 43.61%, marking a year-over-year increase of 624300.0%. This contributed to the annual value of 37.5% for FY2024, which is 93600.0% up from last year.
  • Ptc Therapeutics' Operating Margin amounted to 1.43% in Q3 2025, which was up 291300.0% from 19.54% recorded in Q2 2025.
  • Over the past 5 years, Ptc Therapeutics' Operating Margin peaked at 82.5% during Q1 2025, and registered a low of 119.67% during Q4 2022.
  • Over the past 5 years, Ptc Therapeutics' median Operating Margin value was 54.58% (recorded in 2022), while the average stood at 45.65%.
  • Per our database at Business Quant, Ptc Therapeutics' Operating Margin surged by 1644900bps in 2021 and then tumbled by -780700bps in 2024.
  • Ptc Therapeutics' Operating Margin (Quarter) stood at 51.28% in 2021, then plummeted by -133bps to 119.67% in 2022, then skyrocketed by 102bps to 1.9% in 2023, then tumbled by -4119bps to 76.18% in 2024, then soared by 102bps to 1.43% in 2025.
  • Its last three reported values are 1.43% in Q3 2025, 19.54% for Q2 2025, and 82.5% during Q1 2025.